Mark W Hahn

Chief Financial Officer

Mark W Hahn (Chief Financial Officer) filed 10 Form 4 reports in the past 24 months (0 purchases, 10 sales), most often in VRNA. The largest single filing was $5.3M of VRNA (587,008 sh across 3 lots, as filed), executed May 1 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 10 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$25.6M

shares × price, as filed

Last traded

Aug 1 2025

Filed Aug 5 2025

Open performance→

Volume by month

Buys $0 Sells $25.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Not on file 10 filings

Sector per market data · by filing · past 24 months

Most traded names

VRNA VRNA VRNA · 0 buys · 10 sells 10 filings

Recent filings

VRNASALE Verona Pharma plc View filing → $2.7M
208,912 sh × $13.14
Exec Aug 1 2025
Filed Aug 5 2025 · 5:30 PM ET VRNASALE Verona Pharma plc View filing → $4.6M
400,000 sh × $11.40
Exec Jun 11 2025
Filed Jun 13 2025 · 5:30 PM ET VRNASALE Verona Pharma plc View filing → $3.7M
400,000 sh across 3 lots
Exec May 27 2025
Filed May 29 2025 · 5:30 PM ET VRNASALE Verona Pharma plc View filing → $5.3M
587,008 sh across 3 lots
Exec May 1 2025
Filed May 5 2025 · 5:30 PM ET VRNASALE Verona Pharma plc View filing → $811K
90,360 sh × $8.98
Exec Apr 29 2025
Filed May 1 2025 · 5:30 PM ET VRNASALE Verona Pharma plc View filing → $4.4M
881,960 sh across 3 lots
Exec Dec 4 2024
Filed Dec 6 2024 · 5:30 PM ET VRNASALE Verona Pharma plc View filing → $495K
98,704 sh × $5.01
Exec Nov 29 2024
Filed Dec 2 2024 · 5:30 PM ET VRNASALE Verona Pharma plc View filing → $569K
129,672 sh across 2 lots
Exec Nov 1 2024
Filed Nov 5 2024 · 5:30 PM ET More filings →